Risk factors for gastrointestinal bleeding: A hospital-based case-control study

Swiss Medical Weekly

Volumn 137, Issue 49-50, 2007, Pages 705-710

  Vonbach, Priska ^a   Reich, Rahel ^b   Möll, Friedrich ^a   Krähenbühl, Stephan ^c   Ballmer, Peter E ^d   Meier, Christoph R ^c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

Anticoagulants; Case control study; Gastrointestinal bleeding; Hospitalization; Nonsteroidal antiinflammatory drug

Indexed keywords

ACEMETACIN; ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETAMETHASONE; CELECOXIB; CITALOPRAM; CLOPIDOGREL; CORTISONE; DICLOFENAC; DIPYRIDAMOLE; ETODOLAC; FLUOXETINE; GLUCOCORTICOID; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; MEFENAMIC ACID; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PHENPROCOUMON; PREDNISOLONE; PREDNISONE; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RISK FACTOR;

EID: 37749011361     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15-9.
2. van der Hooft CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BH. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf. 2006;29:161-8.
3. Lepori V, Perren A, Marone C. Adverse internal medicine drug effects at hospital admission. Schweiz Med Wochenschr. 1999;129:915-22.
4. Knijff-Dutmer EA, Schut GA, van de Laar MA. Concomitant coumarin-NSAID therapy and risk for bleeding. Ann Pharmacother. 2003;37:12-6.
5. Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med. 2005;165:189-92.
6. Mamdani M, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. Bmj. 2002;325:624.
7. Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Evaluation of drug interaction screening programs. Forum Med Suisse. 2005;8 S:P15.
8. e-mediat. Pharmavista - information for healthcare professionals. Version February 2005 ed: e-mediat AG, Schönbühl, Switzerland, 2005.
9. Breen AB, Vaskinn TE, Reikvam A, Skovlund E, Lislevand H, Madsen S. Warfarin treatment and bleeding. Tidsskr Nor Laegeforen. 2003;123:1835-7.
10. Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. Chest. 2004;126:1938-45.
11. Fihn SD, Gadisseur AA, Pasterkamp FC, van der Meer FJ, Breukink-Engbers WG, Geven-Boere LM, et al. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon. Thromb Haemost. 2003;90:260-6.
12. Mahe I, Bal Dit Sollier C, Duru G, Lamarque H, Bergmann JF, Drouet L. Use and monitoring of vitamin K antagonists in everyday medical practice. Presse Med. 2006;35:1797-803.
13. Neree C. Quality of oral anticoagulation in patients with atrial fibrillation: A cross-sectional study in general practice. Eur J Gen Pract. 2006;12:163-8.
14. Hallas J, Lauritsen J, Villadsen HD, Gram LF. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol. 1995;30:438-44.
15. Mellemkjaer L, Blot WJ, Sorensen HT, Thomassen L, McLaughlin JK, Nielsen GL, et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol. 2002;53:173-81.
16. Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf. 2004;27:411-20.
17. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology. 2001;120:594-606.
18. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114:735-40.
19. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut. 2000;46:27-31.
20. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med. 1993;153:1665-70.
21. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;95:315-28.
22. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316-21.
23. Lau HS, Florax C, Porsius AJ, De Boer A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol. 2000;49:597-603.
24. Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005;165:424-9.
25. Abdolrasulnia AI, Weichold N, Shewchuk R, Saag K, Cobaugh DJ, LaCivita CC, et al. Agreement between medical record documentation and patient-reported use of nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm. 2006;63:744-7.
26. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Cmaj. 2005;173:510-5.
27. Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ. 1996;312:1563-6.
28. Greenland S, Schwartzbaum JA, Finkle WD. Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol. 2000;151:531-9.